Bibliometric Analysis of Global Scientific Production on COVID-19 and Vaccines

Author:

Sousa Neto Antonio Rosa de1ORCID,Carvalho Ana Raquel Batista de1,Ferreira da Silva Márcia Daiane1,Rêgo Neta Marly Marques1,Sena Inara Viviane de Oliveira1,Almeida Rosângela Nunes1,Filha Francidalma Soares Sousa Carvalho1,Lima e Silva Laianny Luize1,Costa Girlene Ribeiro da1,Lira Ivana Mayra da Silva1,Portela Denise Maria Meneses Cury2,Oliveira e Silva Amanda Tauana3,Rabêlo Cristiane Borges de Moura1,Valle Andreia Rodrigues Moura da Costa1,Moura Maria Eliete Batista1,Freitas Daniela Reis Joaquim de4

Affiliation:

1. Nursing Department, Federal University of Piaui, Teresina 64049-550, Brazil

2. Department of Medicine, Centro Universitário Uninovafapi, Teresina 64073-505, Brazil

3. Health Sciences Center, Federal University of Piaui, Teresina 64001-020, Brazil

4. Department of Parasitology and Microbiology, Federal University of Piaui, Teresina 64049-550, Brazil

Abstract

This bibliometric analysis aims to analyze the global scientific production of COVID-19 and vaccines. First, a search for scientific articles was performed using the advanced query in the Web of Science™ database, more precisely in its core collection, on 18 February 2023. Data from 7754 articles were analyzed using the Bibliometrix R package and the Biblioshiny application. The evaluated articles were published mainly in 2022 (60%). The scientific journals that published the most about COVID-19 and vaccines were “Vaccines”, “Vaccine” and “Human Vaccines & Immunotherapeutics”. The University of Oxford was the most productive institution, with the authors of the articles mainly originating from the United States, China and the United Kingdom. The United States, despite having carried out the most significant number of collaborations, published mainly with local researchers. The 15 most cited articles and the KeyWords Plus™ evidenced the focus of the published articles on the safety and efficacy of vaccines against COVID-19, as well as on the evaluation of vaccine acceptance, more specifically on vaccine hesitancy. Research funding came primarily from US government agencies.

Funder

National Council for Scientific and Technological Development

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Reference77 articles.

1. A 50-Year Overview of the Coronavirus Family with Science Mapping Techniques: A Review;Tabur;Iran. J. Public Health,2021

2. Xu, J., Zhao, S., Teng, T., Abdalla, A.E., Zhu, W., Xie, L., Wang, Y., and Guo, X. (2020). Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS–CoV-2 and SARS-CoV. Viruses, 12.

3. Khan, M., Adil, S.F., Alkhathlan, H.Z., Tahir, M.N., Saif, S., Khan, M., and Khan, S.T. (2020). COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Molecules, 26.

4. World Health Organization (2023, January 01). Advice for the Public: Coronavirus Disease (COVID-19). Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public.

5. Meyer, H., Ehmann, R., and Smith, G.L. (2020). Smallpox in the post-eradication era. Viruses, 12.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3